Comparing a new hormone injection to Ovidrel in healthy women
Part of Women’s health & pregnancy clinical trials.
This study compares a new injected hormone (SJ04) with a standard one (Ovidrel) to see if they work similarly. It's for healthy women with regular cycles who might need help with fertility treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 20 and 40 years old.
- You are generally healthy with no major chronic illnesses.
- Your menstrual cycle is regular (25–34 days) or was regular before starting birth control pills.
- You have not used certain hormone medications (like LH or hCG) in the past 3 months.
- Your weight is at least 99 pounds (45 kg) and your body mass index (BMI) is between 19 and 26.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding a hormone called r-hLH to standard IVF treatment helps women aged 35 to 40 produce better eggs and improve their chances of pregnancy. It is for women who are on their first or second cycle of assisted reproduction.
This study tests if a combination of two hormone drugs (follitropin alfa/lutropin alfa) works as well as another drug (hMG) for Japanese women with low LH and FSH levels who are doing in vitro fertilization (IVF). The goal is to help them produce eggs for pregnancy.
This trial compares two ways of taking a medication that helps control your hormones during IVF (in vitro fertilization), one as a pill and one as an injection, to see if the pill works just as well. It also includes a third group who get a different type of hormone treatment. This could help make IVF more convenient for you.
This trial compares two doses of follicle-stimulating hormone (FSH) to find out which dose helps women with normal ovarian reserve have better IVF outcomes. It aims to improve the chances of a successful pregnancy.
This trial tests two different starting doses of a fertility drug (follicle-stimulating hormone, or FSH) during a specific IVF preparation method called PPOS. The goal is to see which dose leads to better egg development for women with good fertility prospects.
This study compares two methods of stimulating the ovaries before IVF: one using a standard hormone (hCG) and another using a different protocol. The goal is to see if the new method works as well as the standard one, while possibly being more cost-effective.
Hear when a new Assisted Reproductive Technology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.